EFBEMALENOGRASTIM ALFA-VUXW

EFBEMALENOGRASTIM ALFA-VUXW was reported 45 times

These side effects are most commonly reported by patients taking EFBEMALENOGRASTIM ALFA-VUXW:

# Side effect Count
0 ANAPHYLACTIC SHOCK 11
1 ASTHENIA 8
2 DIZZINESS 7
3 CHEST DISCOMFORT 5
4 DYSPNOEA 5
5 NAUSEA 5
6 HYPERHIDROSIS 4
7 PYREXIA 4
8 WHITE BLOOD CELL COUNT INCREASED 4
9 BLOOD PRESSURE DECREASED 3
10 MYELOSUPPRESSION 3
11 NEUTROPHIL COUNT DECREASED 3
12 NEUTROPHIL COUNT INCREASED 3
13 OXYGEN SATURATION DECREASED 3
14 PALLOR 3
15 PALPITATIONS 3
16 PERIPHERAL COLDNESS 3
17 SYNCOPE 3
18 WHITE BLOOD CELL COUNT DECREASED 3
19 ATRIAL FLUTTER 2
20 PAIN 2
21 UNDERDOSE 2
22 VOMITING 2
23 ABDOMINAL PAIN 1
24 ALANINE AMINOTRANSFERASE INCREASED 1
25 AMAUROSIS FUGAX 1
26 ANAEMIA 1
27 ANAPHYLACTOID REACTION 1
28 ASPARTATE AMINOTRANSFERASE INCREASED 1
29 BACK PAIN 1
30 BILE ACIDS INCREASED 1
31 BLOOD BILIRUBIN INCREASED 1
32 BLOOD TRIGLYCERIDES INCREASED 1
33 C-REACTIVE PROTEIN INCREASED 1
34 CONFUSIONAL STATE 1
35 CYANOSIS 1
36 DECREASED APPETITE 1
37 DIABETES MELLITUS 1
38 DISCOMFORT 1
39 DRUG ERUPTION 1
40 DRUG HYPERSENSITIVITY 1
41 FACE OEDEMA 1
42 GLUCOSE URINE PRESENT 1
43 GRIMACING 1
44 HEART RATE DECREASED 1
45 HEPATIC FUNCTION ABNORMAL 1
46 HYPERGLYCAEMIA 1
47 HYPOAESTHESIA ORAL 1
48 HYPOALBUMINAEMIA 1
49 HYPOCALCAEMIA 1
50 HYPONATRAEMIA 1
51 HYPORESPONSIVE TO STIMULI 1
52 HYPOTENSION 1
53 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
54 LEUKOCYTOSIS 1
55 LEUKOPENIA 1
56 LOSS OF CONSCIOUSNESS 1
57 LOW DENSITY LIPOPROTEIN INCREASED 1
58 MYOCARDIAL NECROSIS MARKER INCREASED 1
59 NEUTROPHIL COUNT ABNORMAL 1
60 ORTHOSTATIC HYPOTENSION 1
61 PLATELET COUNT DECREASED 1
62 PNEUMONIA 1
63 PNEUMONITIS 1
64 PULSE ABNORMAL 1
65 RESPIRATORY RATE INCREASED 1
66 SUPRAVENTRICULAR EXTRASYSTOLES 1
67 TACHYPNOEA 1
68 TEMPERATURE INTOLERANCE 1
69 THROAT TIGHTNESS 1
70 URTICARIA 1